# Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

> **NCT06617312** · PHASE2 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 64 (estimated)

## Conditions studied

- Smoking Cessation
- Tobacco Use Disorder

## Interventions

- **DRUG:** Cytisinicline
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT06617312
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-05
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06617312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06617312, "Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06617312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*